Greenwich LifeSciences (GLSI) Stock: Buy, Sell, or Hold?
$16.43
+0.36 (+2.24%)
â˛
5d:
+0.49%
30d:
+6.0%
90d:
+0.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
46/100
Position
FAIR
30-Day Fair Range
$15.18 â $17.29
Position: FAIR
Forward P/E & Valuation
-13.7x
Next 12M consensus est.
Wall Street Target
$57.00
+254.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$14.11 / $19.50
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GLSI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GLSI is currently trading at $16.43, which is considered fair relative to its 30-day fair value range of $15.18 to $17.29.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $14.11, while resistance sits at $19.50.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $57.00 (+254.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $14.11, while resistance sits at $19.50.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $57.00 (+254.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.18 -
$17.29
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$15.18 -
$17.29
Current vs Trading Range
FAIR
Support Level
$14.11
Resistance Level
$19.50
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 254.7% below Wall St target ($57.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-13.74
Wall Street Target
$57.00
(+254.7%)
Share GLSI Analysis
Share this live GLSI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GLSI)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expresses anticipation for potential news from $GLSI Bio Europe conference.
Key Retail Themes:
Anticipation for news
Positive sentiment towards $GLSI
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:39 PM ET
Data refreshes hourly during market hours. Next update: 3:39 PM
Data refreshes hourly during market hours. Next update: 3:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GLSI Research Pages
